Originally published on Wed October 10, 2012 6:52 am
When former General Electric CEO Jack Welch tweeted on Friday that the drop in the unemployment rate last month was "unbelievable" and that President Obama and his campaign aides "will do anything ... can't debate so change numbers," he aligned himself with conspiracy theorists who were asking if some sort of "October surprise" had been pulled.
Good morning. I'm Renee Montagne. It was the sort of report card that could crush a budding young talent. In 1949, a teacher at Eton belittled John Gurdon's dreams of becoming a scientist as quite ridiculous. If he can't learn simple biological facts, the teacher sniffed, pursuing science would be a waste of time. Gurdon eventually did go on to study zoology. And this week his breakthrough in reprogramming cells received the Nobel Prize for Medicine. It's MORNING EDITION. Transcript provided by NPR, Copyright NPR.
Americans Robert Lefkowitz and Brian Kobilka have been awarded the 2012 Nobel Prize in Chemistry for their "groundbreaking discoveries" about the "fine-tuned system of interactions between billions of cells" in the human body, the Nobel Prize committee announced this morning.
This week has brought one of the most disturbing images to emerge from years of conflict, in Pakistan. A 15-year-old girl lies in a hospital bed, with a bullet wound in her head. This is her punishment. She had the courage to demand the right for girls to get an education, and because she criticized violent Islamist militants who aim to stop girls, like her, from doing that. From Islamabad, NPR's Philip Reeves reports.
This is MORNING EDITION from NPR News. I'm Renee Montagne.
STEVE INSKEEP, HOST:
And I'm Steve Inskeep. Good morning.
All this week, we've been reporting on the winners of this year's Nobel Prizes. And today in Stockholm, the Royal Swedish Academy of Sciences announced the winners of the Nobel Prize for Chemistry. The chair of the Nobel Prize committee for chemistry described the importance of the discovery by giving the assembled reporters a little scare.
And staying here in California, our last word in business is lights, camera, sold.
The sale of Variety is officially a wrap. The venerable 107-year-old show biz daily has been bought for $25 million by Penske Media, the owner of Variety's upstart online rival Deadline.com. Like its longtime competitor, the Hollywood Reporter, Variety has had trouble making the switch to digital media, but it still turns a profit. So in the language that Variety helped make famous, Penske seems to believe this deal will be boffo and not a flopola.
It's MORNING EDITION from NPR News. I'm Steve Inskeep.
RENEE MONTAGNE, HOST:
And I'm Renee Montagne.
A House committee is investigating last month's attack that killed the ambassador to Libya and three other Americans at a consulate in the city of Benghazi. And today, senior State Department officials will be on the receiving end of politically-charged questions. Republicans say that the Obama administration rejected repeated requests for more security.
For the past decade, scientists have been toying with the notion of encapsulating medicine in microscopic balls.
These so-called nanospheres could travel inside the body to hard-to-reach places, like the brain or the inside of a tumor. One problem researchers face is how to build these nanospheres, because you'd have to make them out of even smaller nanoparticles.
For our series First and Main, Morning Edition is traveling to contested counties in swing states to find out what is shaping voters' decisions this election season. The latest trip took us to Larimer County, Colo.